At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 428 enrolled
Drug / intervention
Etomidate +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Controlled Trial to Evaluate the Hemodynamic Effects of Ketamine Versus Etomidate During Rapid Sequence Intubation
South East Area Health Education Center, Wilmington, NC·interventional·Posted Jun 4, 2018·Updated Nov 26, 2021
In Brief
A Phase 4 clinical trial evaluating Etomidate and Ketamine for Intubation Complication. Completed, enrolled 428 participants across 1 site.
Detailed Summary
The purpose of this study is to compare the hemodynamic effects of ketamine v etomidate during rapid sequence intubation (RSI) in the pre-hospital and emergency department setting.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIntubation Complication
CountriesUnited States
CollaboratorsNew Hanover Regional Medical Center
Timeline
Phase 4CompletedFinished
201820192020202120222023202420252026
Enrollment StartJan 2018
First PostedJun 2018
Primary CompletionSep 2019
TodayJul 2026
First PostedJun 4, 2018
Enrollment StartJan 1, 2018
Primary CompletionSep 1, 2019
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 8.1 years ago
Interventions
Etomidatedrug
Etomidate will be administered as the sedative for RSI on even days
Ketaminedrug
Ketamine will be administered as the sedative for RSI on odd days